Groundbreaking research reveals MDM2's independent role in driving breast cancer metastasis through pathways separate from p53, opening new treatment possibilities.
Discover how MDM2 SNP309, a single genetic variation, increases nasopharyngeal carcinoma risk and metastasis in Chinese populations.
Explore the revolutionary combination therapy of MDM2 inhibitors and ONC201 for treating solid tumors with MDM2 overexpression.
Explore the complex role of MDM2 in cancer prognosis, from its relationship with p53 to therapeutic approaches and future research directions.